Valeritas, Inc., a company focused on the development of technologies for patients with type 2 diabetes, has released positive results of a new evaluation of its insulin delivery device, the V-Go®. The article documenting the analysis is entitled “Use of V-Go® Insulin Delivery Device in Patients with Sub-optimally Controlled Diabetes Mellitus: A Retrospective Analysis from a Large Specialized Diabetes System” and was recently published in the journal Diabetes Therapy.
